EClinicalMedicine
Journal
Overview
publication venue for
-
Apomorphine for prolonged disorders of consciousness: a multimodal open-label study..
78.
2024
-
Multivariable models of outcomes with [177Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial..
77.
2024
-
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial..
75.
2024
-
Association between acquiring SARS-CoV-2 during pregnancy and post-acute sequelae of SARS-CoV-2 infection: RECOVER electronic health record cohort analysis..
73.
2024
-
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022..
71.
2024
-
Effects of RBT-1 on preconditioning response biomarkers in patients undergoing coronary artery bypass graft or heart valve surgery: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial..
68.
2024
-
Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study..
67.
2023
-
Hepatitis C infection seroprevalence in pregnant women worldwide: a systematic review and meta-analysis..
66.
2023
-
Effective questionnaire-based prediction models for type 2 diabetes across several ethnicities: a model development and validation study..
64.
2023
-
An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort study..
64.
2023
-
Large-scale identification of undiagnosed hepatic steatosis using natural language processing..
62.
2023
-
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study..
62.
2023
-
Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial..
60.
2023
-
Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer..
60.
2023
-
SARS-CoV-2 seroprevalence in children worldwide: A systematic review and meta-analysis..
56.
2022
-
The iR2 regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: A multicentre, non-randomised, open-label phase 2 study..
56.
2022
-
The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis..
54.
2022
-
Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: A longitudinal, multicentre, cohort study..
53.
2022
-
Mortality in HIV and tuberculosis patients following implementation of integrated HIV-TB treatment: Results from an open-label cluster-randomized trial..
44.
2022
-
Epidemiology of herpes simplex virus type 2 in sub-Saharan Africa: Systematic review, meta-analyses, and meta-regressions..
35.
2021
-
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy..
35.
2021
-
Antibody titers against SARS-CoV-2 decline, but do not disappear for several months..
32.
2021
-
Time to establish an international vaccine candidate pool for potential highly infectious respiratory disease: a community's view.
2023
Identity
ISO Abbreviation
Linking ISSN
Electronic International Standard Serial Number (EISSN)